Adam H. Schechter serves as the President and Chief Executive Officer of LabCorp Holdings Inc., a leading global life sciences company that provides diagnostic and drug development services. With a career spanning several decades in the healthcare industry, Schechter has been instrumental in steering LabCorp towards significant growth and innovation. He joined LabCorp in 2019, bringing with him a wealth of experience from his previous roles, including his tenure as the CEO of LabCorp Diagnostics. Prior to joining LabCorp, Schechter held various leadership positions at major healthcare organizations. He spent over 25 years at Johnson & Johnson, where he served as the Worldwide Chairman of the company's Pharmaceuticals Group. During his time there, he played a pivotal role in expanding the company's pharmaceutical portfolio and strengthening its global presence. Schechter's strategic vision and leadership skills have been key factors in his successful career, earning him recognition as a transformative leader in the healthcare sector. As CEO of LabCorp, Schechter has focused on advancing the company's mission to improve health and improve lives. Under his leadership, LabCorp has expanded its capabilities in diagnostics and drug development, leveraging cutting-edge technologies to enhance patient care and accelerate the development of new therapies. Schechter's commitment to innovation and excellence has positioned LabCorp as a leader in the life sciences industry, driving the company's growth and solidifying its reputation for delivering high-quality, reliable services.